Physician
Southland Hematology Oncology Medical Group, INC
Southland Hematology Oncology Medical Group, INC was paid $2.69M by Medicaid between Jan 2018 and Nov 2024, across 23 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 65% of everything it billed.
33Billing provider infoSOUTHLAND HEMATOLOGY ONCOLOGY MEDICAL GROUP, INC
HEMET, CA 92543
HEMET, CA 92543
33aNPI1952301947assigned 07/30/2005
33bProvider typeHematology & Oncology Physician
28Total paid$2.69M
24GClaims55,421
24DCodes billed23
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in California
Rank by total paid#9 of 180
Median peer was paid$26K
This provider vs. median105×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,335 | $361K | |
| 2019 | 10,268 | $412K | |
| 2020 | 7,237 | $346K | |
| 2021 | 7,672 | $439K | |
| 2022 | 6,335 | $382K | |
| 2023 | 8,815 | $398K | |
| 2024incomplete | 7,759 | $349K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 65% | 16,365 | 13,228 | $1.74M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 9.6% | 3,856 | 2,342 | $258K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 8.4% | 2,008 | 917 | $224K |
| 96367 | 3.8% | 3,972 | 1,819 | $102K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.5% | 5,337 | 3,424 | $66K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.3% | 420 | 420 | $63K |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 1.7% | 2,299 | 1,408 | $46K |
| 99443 | 1.4% | 1,028 | 962 | $37K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.3% | 1,752 | 1,096 | $35K |
| 96415 | <1% | 1,013 | 341 | $25K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 320 | 302 | $22K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,763 | 611 | $20K |
11 more codes
| 99205 | Prolong outpt/office vis | <1% | 90 | $17K |
| 99195 | <1% | 74 | $7K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,525 | $7K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 4,116 | $6K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 1,138 | $6K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 3,947 | $4K |
| J1750 | Injection, iron dextran, 50 mg | <1% | 36 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,555 | $2K |
| 96417 | <1% | 25 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 106 | $1K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 676 | $506.93 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTSAI, JAMES (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| New York Eye & Ear Infirmary | New York City, NY | $38.92M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.